Compare with BLISS GVS PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ANG LIFESCIENCES INDIA vs BLISS GVS PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ANG LIFESCIENCES INDIA BLISS GVS PHARMA ANG LIFESCIENCES INDIA/
BLISS GVS PHARMA
 
P/E (TTM) x - 12.8 - View Chart
P/BV x 16.7 1.3 1,245.3% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ANG LIFESCIENCES INDIA   BLISS GVS PHARMA
EQUITY SHARE DATA
    ANG LIFESCIENCES INDIA
Mar-20
BLISS GVS PHARMA
Mar-21
ANG LIFESCIENCES INDIA/
BLISS GVS PHARMA
5-Yr Chart
Click to enlarge
High Rs66224 29.4%   
Low Rs2886 32.8%   
Sales per share (Unadj.) Rs244.856.0 437.6%  
Earnings per share (Unadj.) Rs11.87.2 164.1%  
Cash flow per share (Unadj.) Rs14.18.8 159.9%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Avg Dividend yield %00.3 0.0%  
Book value per share (Unadj.) Rs66.777.4 86.2%  
Shares outstanding (eoy) m5.18103.15 5.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.22.8 6.9%   
Avg P/E ratio x4.021.6 18.5%  
P/CF ratio (eoy) x3.317.5 19.0%  
Price / Book Value ratio x0.72.0 35.2%  
Dividend payout %07.0 0.0%   
Avg Mkt Cap Rs m24315,988 1.5%   
No. of employees `000NANA-   
Total wages/salary Rs m71681 10.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,2685,772 22.0%  
Other income Rs m4202 2.1%   
Total revenues Rs m1,2735,974 21.3%   
Gross profit Rs m1271,066 11.9%  
Depreciation Rs m12172 7.1%   
Interest Rs m3555 62.8%   
Profit before tax Rs m841,041 8.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m23302 7.7%   
Profit after tax Rs m61740 8.2%  
Gross profit margin %10.018.5 54.1%  
Effective tax rate %27.529.0 94.9%   
Net profit margin %4.812.8 37.5%  
BALANCE SHEET DATA
Current assets Rs m7277,652 9.5%   
Current liabilities Rs m5092,036 25.0%   
Net working cap to sales %17.297.3 17.7%  
Current ratio x1.43.8 38.0%  
Inventory Days Days148 1.2%  
Debtors Days Days1332,933 4.5%  
Net fixed assets Rs m2143,116 6.9%   
Share capital Rs m52103 50.2%   
"Free" reserves Rs m2947,881 3.7%   
Net worth Rs m3467,984 4.3%   
Long term debt Rs m53326 16.1%   
Total assets Rs m94110,768 8.7%  
Interest coverage x3.419.9 17.2%   
Debt to equity ratio x0.20 372.1%  
Sales to assets ratio x1.30.5 251.5%   
Return on assets %10.27.4 137.7%  
Return on equity %17.69.3 190.4%  
Return on capital %29.813.2 226.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m153,813 0.4%   
Fx outflow Rs m1745 0.1%   
Net fx Rs m143,067 0.5%   
CASH FLOW
From Operations Rs m48640 7.6%  
From Investments Rs m-17-470 3.5%  
From Financial Activity Rs m-39-208 19.0%  
Net Cashflow Rs m-8-22 35.0%  

Share Holding

Indian Promoters % 71.1 33.2 214.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 27.7 -  
FIIs % 0.0 21.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 28.9 66.8 43.3%  
Shareholders   323 42,742 0.8%  
Pledged promoter(s) holding % 21.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ANG LIFESCIENCES INDIA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Ends 157 Points Higher; ITC, L&T and Asian Paints Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

BLISS GVS PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of BLISS GVS PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of BLISS GVS PHARMA. Also includes updates on the valuation of BLISS GVS PHARMA.

BLISS GVS PHARMA Announces Quarterly Results (1QFY22); Net Profit Up 56.9% (Quarterly Result Update)

Aug 3, 2021 | Updated on Aug 3, 2021

For the quarter ended June 2021, BLISS GVS PHARMA has posted a net profit of Rs 261 m (up 56.9% YoY). Sales on the other hand came in at Rs 2 bn (up 29.8% YoY). Read on for a complete analysis of BLISS GVS PHARMA's quarterly results.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

6 Penny Stocks that Rallied 1,000%+ in One Year(Views On News)

Dec 6, 2021

These penny stocks shed their penny status by surging 1,000% or more in the last one year.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ANG LIFESCIENCES INDIA SHARE PRICE


Dec 9, 2021 (Close)

TRACK ANG LIFESCIENCES INDIA

  • Track your investment in ANG LIFESCIENCES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ANG LIFESCIENCES INDIA

ANG LIFESCIENCES INDIA - CIPLA COMPARISON

COMPARE ANG LIFESCIENCES INDIA WITH

MARKET STATS